Related Experiment Video

Updated: Aug 10, 2026

Intravenous Injections in Neonatal Mice
05:17

Intravenous Injections in Neonatal Mice

Published on: November 11, 2014

Treatment of bacterial meningitis in children without intravenous fluids

F Shann, S Germer

    The Medical Journal of Australia
    |May 30, 1981
    PubMed

    Insights

    Bacterial meningitis can be effectively treated using intramuscular benzyl penicillin and oral probenecid and chloramphenicol. This approach reduces risks associated with intravenous fluid administration, offering a simpler, cheaper, and safer alternative for most pediatric cases.

    Area of Science:

    • Pediatrics
    • Infectious Diseases
    • Pharmacology

    Background:

    • Bacterial meningitis treatment traditionally involves intravenous fluid administration.
    • Intravenous fluids carry risks, including cerebral edema.
    • Alternative, less invasive treatment methods are desirable for improved patient outcomes and reduced healthcare costs.

    Purpose of the Study:

    • To evaluate the efficacy and safety of treating bacterial meningitis in children without intravenous fluid administration.
    • To compare mortality rates between a novel intramuscular/oral treatment regimen and a standard intravenous regimen.
    • To determine if non-intravenous therapy is a viable and effective alternative for bacterial meningitis management.

    Main Methods:

    • Prospective evaluation of 50 children with bacterial meningitis treated with intramuscular benzyl penicillin, oral probenecid, and oral chloramphenicol palmitate.
    • Retrospective analysis of a control group of 50 children with bacterial meningitis treated with intravenous benzyl penicillin and intravenous chloramphenicol sodium succinate.
    • Comparison of mortality rates between the two treatment groups.

    Main Results:

    • The prospective group (intramuscular/oral) had a mortality rate of 14% (7 out of 50 children).
    • The retrospective control group (intravenous) had a mortality rate of 24% (12 out of 50 children).
    • The difference in mortality rates was not statistically significant, suggesting comparable efficacy.

    Conclusions:

    • Bacterial meningitis can be effectively treated with six-hourly intramuscular injections of penicillin combined with oral probenecid and chloramphenicol.
    • This non-intravenous approach is recommended except in rare cases of shock or persistent vomiting.
    • The findings suggest a potentially safer, more cost-effective, and logistically simpler treatment strategy for pediatric bacterial meningitis.

    More Related Videos

    Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain05:51

    Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain

    Published on: July 24, 2016

    Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery10:03

    Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

    Published on: November 5, 2019

    Related Concept Videos

    Acute Pyelonephritis II: Diagnostic Studies and Management01:28

    Acute Pyelonephritis II: Diagnostic Studies and Management

    Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
    Rocky Mountain Spotted Fever01:26

    Rocky Mountain Spotted Fever

    Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
    Bacterial Meningitis01:24

    Bacterial Meningitis

    Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
    Viral Meningitis01:18

    Viral Meningitis

    Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
    Bacterial Meningitis I: Introduction01:22

    Bacterial Meningitis I: Introduction

    Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
    Bacterial Meningitis II: Pathophysiology01:26

    Bacterial Meningitis II: Pathophysiology

    Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...